Brightspring Health Services, Inc. · NASDAQ:BTSG

Brightspring Health Services — Investor Presentation (July 2026)

25 slides from Brightspring Health Services's investor presentation, July 2026

  1. Slide 1: Overview Presentation

    Overview Presentation July 2026 1

  2. Slide 2: Forward-Looking Statements; Non-GAAP Financial Information

    Forward-Looking Statements; Non-GAAP Financial Information Forward-Looking Statements • factors outside of our control, including those listed, which have required and could in the future require us to record an asset impairment of goodwill; • No Image a pandemic, epidemic, or outbreak of an infecti

  3. Slide 3: A leading pharmacy and health care provider in the U.S.

    A leading pharmacy and health care provider in the U.S., serving large and growing markets that have significant unmet needs, with high-quality and integrated services that improve outcomes and reduce cost 3

  4. Slide 4: BrightSpring At A Glance

    BrightSpring At A Glance Providing Needed Solutions ✓ Serving large and growing healthcare populations, characterized by high-cost, high-acuity, and significant complexity, with patient-centered and high-quality services delivered in preferred and lower-cost home and community settings Focus on Oper

  5. Slide 5: The Problem: Care Delivery for Complex Senior and Specialty Patients is Not Optimized

    The Problem: Care Delivery for Complex Senior and Specialty Patients is Not Optimized 5% of the Population Represents 50% of Healthcare Spending (1) Hospital ER Doctor’s Office 50% 5% Pharmacy Rehab ~70% of Seniors Have 2+ Chronic Conditions (2)  ER and acute hospital settings for many services tha

  6. Slide 6: The Solution: Lower-Cost, Preferred Settings with BrightSpring's Platform of Services

    The Solution: Lower-Cost, Preferred Settings with BrightSpring’s Platform of Services Lower-Cost and Preferred Settings Comprehensive Care Model Benefits ✓ Enhanced care access Home Community Comprehensive and coordinated ns P ✓ pharmacy and provider services io ro ut vid Sol er S Pharmacy $2,400 er

  7. Slide 7: Demonstrated Operational Strength Drives Growth and Profitability

    Demonstrated Operational Strength Drives Growth and Profitability Attractive Markets Scale Best Practices Execution Secular Growth Driven Critical in Pharmacy Ability to Drive Organizational by Healthcare System and Health Services Across the Enterprise Discipline and Patient Needs ✓ Purchasing ✓ Cl

  8. Slide 8: Unwavering Commitment to Clinical Quality and Execution

    Pharmacy Solutions Segment Provider Services Segment Unwavering Commitment to Clinical Quality and Execution Focus on quality and operational excellence results in highly attractive outcomes Pharmacy Solutions Provider Services 93% Top 20% 73% of branches 4+ STARs SHP Performers Award Reduction in ~

  9. Slide 9: BrightSpring Financial Highlights

    No Image BrightSpring Financial Highlights Second Quarter 2026 $3,873M 23.0% $206M 44.2% Revenue Revenue Growth Adj. EBITDA Adj. EBITDA Growth Second Quarter 2026 ($ in millions) Y/Y Growth Pharmacy Solutions Pharmacy Solutions Revenue $3,407 +22.1% acy Hom arm e an Specialty and Infusion n Ph dC 2,

  10. Slide 10: National Pharmacy Platform with the Infrastructure, Scale, and Capabilities

    Pharmacy Solutions Segment National Pharmacy Platform with the Infrastructure, Scale, and Capabilities to Serve Customers and Complex Populations in Home and Community Settings BrightSpring’s National Pharmacy Platform and Infrastructure Why We Are Successful • In purchasing and contracting, and in

  11. Slide 11: Infusion and Specialty Pharmacy

    Pharmacy Solutions Segment Infusion and Specialty Pharmacy acy Ph arm • Specialty Pharmacy services include coordination of patient services, lty cia education, clinical support, and expert fulfillment pe dS • Infusion therapy services that treat a wide range of acute and chronic health an on condit

  12. Slide 12: Specialty Pharmacy Capabilities

    Pharmacy Solutions Segment Specialty Pharmacy Capabilities Leading independent specialty pharmacy in the U.S. focused on Oncology, Rare Disease, and value-add manufacturer (biopharma) services Critical Success Factors and Differentiated Capabilities ... … Has Driven Significant Patient Growth Over t

  13. Slide 13: Growing Pipeline of Specialty Pharmacy and Infusion Therapies and Generics

    Pharmacy Solutions Segment Growing Pipeline of Specialty Pharmacy and Infusion Therapies and Generics Significant and continued near-term growth expected in the Specialty Pharmacy market, driven by over 250 new Oncology, Rare, and Neuro therapies in Phase III; additionally, fourteen brand drugs that

  14. Slide 14: Home and Community Pharmacy

    Pharmacy Solutions Segment Home and Community Pharmacy • Home and community-based pharmacy solutions ensure that medications are accessible and clinically supported for patients outside of retail pharmacies • Focus on achieving leading medication availability, cost containment, and clinical and regu

  15. Slide 15: Provider Services

    Provider Services Segment Integrated Provider Services Platform that is Complementary with Pharmacy Solutions National Coverage(1) and Targeted Market Density Delivering Critical Services to Patients • Compassionate clinical care support Home for Seniors and other patients in their homes Home Health

  16. Slide 16: Home Healthcare (Home Health, Hospice, Primary Care)

    Provider Services Segment Home Healthcare (Home Health, Hospice, Primary Care) • Patient-centric and compassionate nursing and therapy primarily to senior patients with a variety of illnesses, injuries, and rehabilitation needs • Palliative and hospice services designed to give patients and their fa

  17. Slide 17: Rehab Care

    Provider Services Segment Rehab Care • Highly clinical rehabilitation services help adults and children who have experienced a brain injury, spinal cord injury, or stroke due to injury or illness • Deliver rehab and behavioral therapy for the treatment of pediatric and adult conditions, including I/

  18. Slide 18: Personal Care

    Provider Services Segment Personal Care • Supportive care to seniors who require long-term care and assistance with activities of daily living to maintain their independence at home • Home care support activities address social determinants of health, including dietary and nutrition management, cogn

  19. Slide 19: Home Health and Hospice Complementary to Primary Care, Pharmacy, and Rehab

    Pharmacy Solutions Segment Provider Services Segment Home Health and Hospice Complementary to Primary Care, Pharmacy, and Rehab Home Health and Hospice are central to outcomes and benefit from Hospice is a required component of home-based access to relevant referrals and patients through related ser

  20. Slide 20: Significant Payer Diversification

    Significant Payer Diversification Pharmacy Solutions Payer Diversification(1) 2% 5% 34% Total Company Continuing Operations Payer 31% Diversification (1) 3% 19% 10% 9% Medicare D Medicaid 30% Medicare C Commercial Insurance Medicare A & B Private & Other 29% Provider Services Continuing Operations P

  21. Slide 21: De-leveraging Update and Capital Allocation Priorities

    No Image De-leveraging Update and Capital Allocation Priorities De-leveraging driven by operational performance and capital allocation • Capex investments: 1% of revenue Long-Term Pre IPO / Post-Equity and Debt Transactions Current Leverage Cash Flow • Sustainable net working capital position Levera

  22. Slide 22: Experienced Management Team with a Successful Track Record of Building Companies

    Experienced Management Team with a Successful Track Record of Building Companies 26 Years Average Healthcare Experience on Management Team Jon Rousseau Dr. William Mills President & Chief Senior Vice Executive Officer President, Medical Affairs Daryn Demeritt Jen Phipps Senior Vice Executive Vice Pr

  23. Slide 23: Consistent Growth Strategy Focused on Expanding Core Services, Strategic Growth, and Acquisitions

    Consistent Growth Strategy Focused on Expanding Core Services, Strategic Growth, and Driving Value Through Acquisitions 1 2 3 Core Growth Strategic Growth M&A Continued Execution of Drive Additional Accretive Integrated Care Acquisitions Adjacent Provider Opportunities and Pharmacy Investments patie

  24. Slide 24: BrightSpring: A Leading, Integrated, and Transformative Health Services Company

    BrightSpring: A Leading, Integrated, and Transformative Health Services Company ✓ Large Markets with Growing Demand ✓ Consistent Quality Performance ✓ Serving Preferred, Lower-Cost Settings ✓ Integrated Value-Based Care Capabilities ✓ Comprehensive Platform of Services ✓ Accretive De Novo and M&A Gr

  25. Slide 25: Non-GAAP Reconciliations

    No Image Non-GAAP Reconciliations For the Three Months Ended For the Six Months Ended ($ in thousands) June 30, 2025 June 30, 2026 June 30, 2025 June 30, 2026 Net Income from Continuing Operations $ 8,541 $ 86,604 $ 17,757 $ 160,887 Income Tax Expense 1,238 6,908 998 15,459 Interest Expense, net 38,

BrightSpring Health Services — Investor Presentation (July 2026) on 6ix